Forehead Lines vs Glabellar Lines: Targeting Both with Botox

The single most common upper-face request in my practice is some version of "fix the 11s, but please do not freeze my forehead." It is also the request that goes wrong most often when the provider treats the two areas as a single procedure rather than two related but distinct ones. The forehead and the glabella — the area between your eyebrows where the vertical lines form when you concentrate or frown — are anatomically linked, and what you do to one directly affects the other. Treating them as a coordinated unit produces the natural result patients want. Treating them as a checklist produces the heavy-brow, surprised-expression result everyone is trying to avoid.

This is how I think about the upper face — what the muscles are doing and what I am evaluating when a patient sits in the chair asking for "Botox between the eyebrows."

The anatomy that matters

There are three muscle groups in the upper third of the face, and they work in opposition to each other. Understanding the opposition is the entire reason this conversation has nuance.

The frontalis is the broad sheet of muscle covering the forehead. Its only job is to lift the brow. When you raise your eyebrows in surprise, that is frontalis. The horizontal lines across the forehead are dynamic creases that form because frontalis is the only brow elevator you have.

The glabellar complex — corrugator supercilii, depressor supercilii, and procerus — pulls the brow down and inward. When you frown, concentrate hard, or squint into the sun, those muscles fire. Over years of repetition, they etch the vertical 11s between the eyebrows and the horizontal "bunny line" at the top of the nose.

The orbicularis oculi wraps around the eye. Its lateral fibers are responsible for crow's feet; its upper fibers act as a brow depressor at the tail of the brow.

The opposition is the key fact: frontalis lifts, the glabellar complex and orbicularis depress. Whichever of these you weaken with neuromodulator, you tilt the balance toward its opposite.

Why "just doing the 11s" still affects the rest of the face

When a patient says "just treat the glabella, leave the forehead alone," she is asking for something reasonable — but the result depends on what happens upstream. Weakening the corrugators and procerus removes a chronic downward pull on the medial brow. In a patient with a strong frontalis, the brow actually rises slightly after a glabellar-only treatment. Some patients love that. Some patients with naturally high arches end up looking surprised or quizzical.

The reverse situation — treating the forehead alone — is the one that goes badly more often. If I weaken the frontalis (her only brow elevator) without touching the glabella (her brow depressors), the depressors win the tug-of-war. The brow drops. Patients describe this as feeling heavy, as if their eyelids are sitting on their lashes. In some patients with low resting brow position, even a moderate frontalis treatment is enough to push them into ptosis-adjacent territory. That is the result everyone is afraid of, and it is mechanical, not magical.

Which is why I almost never treat the frontalis without also treating the glabella. The pairing keeps the balance intact and prevents the heavy-brow look. Neuromodulator treatments of the upper face, done well, are an exercise in equilibrium.

What I look for in the assessment

When a patient sits down for an upper-face consultation, the static photo on her phone is not what I am evaluating. I am watching her face move. I have her raise her brows fully. Frown hard. Squint. Concentrate. Speak. Smile. Each motion shows me which muscles are doing the most work, which are dominant, and where the asymmetries are — and most patients have asymmetries they have never noticed.

The list I am running through:

• Resting brow position. High, neutral, low? A low-set brow at rest changes my entire approach to the frontalis. Less product, fewer injection points, sometimes none at all on the lower forehead.
• Brow shape and arch. Patients with a strong natural arch can have it accentuated by certain injection patterns. Patients with a flat brow can sometimes get a subtle lift. Both possibilities have to be discussed before I pick a pattern.
• Frontalis strength and pattern. Some patients have a single solid sheet of frontalis activation. Others have a discontinuous pattern with central or lateral hot spots. The dose map follows the muscle map, not a textbook diagram.
• Glabellar complex strength. A patient who frowns hard her whole life has thicker, stronger corrugators. She needs more product to get an effect. A patient with mild glabellar activity needs less. Same area, different doses.
• Existing static lines versus dynamic lines only. Dynamic lines (only visible when the muscle moves) respond fully to neuromodulator. Static lines (visible at rest, etched into the skin from years of motion) soften with repeated treatment over six to twelve months but rarely disappear from neuromodulator alone. That is where adjunct treatments like microneedling, fractional CO2 laser, or a VI Peel actually earn their place — they remodel the skin itself, which neuromodulator does not do.
• Eyelid position and skin redundancy. A patient with significant upper-eyelid hooding is at higher risk of post-treatment heaviness if frontalis is weakened too much. She needs a more conservative dose, sometimes a lower placement, and an honest conversation that the result will be different from what a 28-year-old without hooding would get.
• Patient goals — and the goals behind the goals. "I want to look less tired" is different from "I want fewer lines." "I want to look refreshed for a wedding in six weeks" is different from "I want to start a long-term plan." I want to understand what she is actually trying to achieve before I pick a dose.

After 17 years of clinical practice — emergency medicine and cardiac care before aesthetic work — I treat the assessment as the most important part of the appointment. The injection is ten minutes. The thinking behind the dose map determines whether the result is good.

How I dose the upper face

I am conservative on first treatments, deliberately. The patient who is overdosed on her first appointment lives with that result for three to four months — she cannot raise her brows, her face does not move when she talks, and she is unhappy for the entire duration. The patient who is underdosed comes back at the two-week follow-up and gets a touch-up with two or three more units in the right spots. That second appointment costs both of us a few minutes; it does not cost anyone four months of dissatisfaction.

The general framework I use, which I will adjust to the patient in front of me:

• Glabellar complex (procerus and corrugators): typically 16 to 24 units of Botox, distributed across five to seven injection points. Stronger corrugators get more.
• Frontalis: typically 6 to 14 units, distributed across four to eight points placed deliberately to preserve some elevation, especially laterally for the natural arch.
• The two areas are dosed together, not separately. The ratio of frontalis-to-glabella product matters as much as the absolute dose.

For frown lines treatment specifically, the conservative-first principle is the same: better to start lighter on the forehead and add a few units at the two-week mark than to start heavier and have her live with a flat, motionless brow.

The longer-term picture

Neuromodulator for the 11s between eyebrows has a benefit that compounds over time. Patients who treat consistently every three to four months for two to three years often need less product to maintain the same result, because the chronic muscle activity that was etching the lines has been quieted long enough for the dermis to recover and the static creases to soften. Patients who treat sporadically — once every nine months when they remember — tend to maintain the same dose requirement indefinitely.

The other long-term piece is that neuromodulator addresses the muscle, not the skin. A 50-year-old patient with significant static glabellar lines, sun damage, and thinning skin gets a partial result from neuromodulator alone. The full result usually comes from neuromodulator plus a skin-quality intervention — microneedling every three to four months, a VI Peel seasonally, an AquaFirme facial in between for hydration and barrier support, occasional fractional CO2 laser for deeper texture work, or a vampire facial for collagen remodeling. Some patients also benefit from small-volume dermal filler treatments at the lateral brow or temples to support the bony framework that has lost volume. The combination is what produces the result that patients describe as looking refreshed rather than treated.

What I will not do

There are requests I turn down at the consultation, and I would rather be honest about that up front than perform a treatment I think will produce a bad result.

• I will not over-flatten a forehead in a patient who already has heavy brow position. That is a recipe for ptosis and post-treatment regret.
• I will not chase a result that requires fixing the brow itself rather than the muscles around it. A patient who actually needs a surgical brow lift gets a referral, not a workaround with neuromodulator.
• I will not treat a patient who cannot articulate what she wants. If "fix my face" is the only goal, we slow down and talk before anyone gets injected. The clearest-spoken patient gets the best result.
• I will not push add-on treatments she did not ask about. If she came for the 11s and the 11s are what she needs, that is the appointment.

Your next step

If you have been thinking about treating the upper face — whether you have done it before with a result you did not love, or you have never done it at all — the consultation is where the actual decision gets made. Bring photos if you have them, including any from prior treatments. Tell me what you liked, what you did not, and what you are trying to achieve. The treatment is brief and the same day; the planning is the part that matters.

We see patients at both the Columbus and Warner Robins clinics on a published rotating schedule, and the dosing philosophy and product selection are identical at both. Book online at whichever location is more convenient. The first appointment is a real conversation, not a sales pitch — and if the right answer for you is a smaller treatment than you came in for, that is what I will recommend.

*Information in this article is educational and does not constitute medical advice. Aesthetic recommendations require an in-person assessment. Individual results vary.*

TW

Travis Woodley

MSN, RN, CRNP — Platinum Biote Provider — Founder, Revitalize

Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.

About Travis →More articles →Rebuild Institute →